FDA approves Dornier's thermotherapy device:
This article was originally published in Clinica
The FDA has approved Dornier MedTech's microwave thermotherapy device to treat benign prostatic hyperplasia. According to the Georgia-based company, the portable and compact Urowave unit delivers 90 watts of power to the tissue, which was "more than any other product on the market". The device, which also offers fully-automated software, has a urethral therapy probe which allows 360-degree cooling.
You may also be interested in...
GSK commits to investing behind OTC and oral health brands in India after offloading nutrition assets to Unilever.
The Belgian biotech has managed to attract considerable sums from venture capitalists over the past couple of years amid hopes that its two next-generation immunotherapies will be best-in-class agents.
Cipla is celebrating an “important milestone” for the company after the successful completion of a Phase III clinical trial comparing its proposed Advair generic with GSK’s brand in the US. Management has cautioned that approval will be a way off yet, however.